Tag: Kidney Cancer

1. Recurrence-free survival was significantly different between the adjuvant everolimus and placebo groups. 2. Grade 3 or higher adverse events ...

1. Progression-free and overall survival was comparable in both the intervention and control groups. 2. Serious adverse events were more ...

1. Disease-free survival in the placebo group was 50.7 months and was never reached in the intervention group; however, there ...

Originally published by Harvard Health. What Is It? The kidneys are a pair of bean-shaped, fist-sized organs below the rib cage ...